IRS1 and lung carcinoma: MiR-126 has been widely reported as a tumour suppressor in lung cancer due to targeting IRS1, EGFL7, Crk, and SLC7A51318, or by means of inhibiting angiogenesis and lung metastasis during lung cancer28,29.